Shares of ResMed (NYSE:RMD) on Thursday slumped as much as 10.7% in extended trading, after the medical device company's quarterly gross margins came under pressure and its revenue missed estimates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback